Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Stay Active to Stay Young
February 15, 2019
Helping People Who Are Socially Isolated Using a Robot
February 15, 2019
Caring for our Carers
February 15, 2019
Yoga Can Help Asthmatics
February 15, 2019
Boosting empathy-based medicine
February 15, 2019
Fight Pain with Food
February 15, 2019
Allergies that start in adulthood
February 15, 2019
So I Can Breathe
February 15, 2019
Better Protection from Hay Fever
February 15, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video